Physiologically Based Pharmacokinetic Models of Probenecid and Furosemide to Predict Transporter Mediated Drug-Drug Interactions

被引：0
|
作者：
Hannah Britz
Nina Hanke
Mitchell E. Taub
Ting Wang
Bhagwat Prasad
Éric Fernandez
Peter Stopfer
Valerie Nock
Thorsten Lehr
机构：
[1] Saarland University,Clinical Pharmacy
[2] Drug Metabolism and Pharmacokinetics,Department of Pharmaceutical Sciences
[3] Boehringer Ingelheim Pharmaceuticals Inc.,undefined
[4] Washington State University,undefined
[5] Translational Medicine and Clinical Pharmacology,undefined
[6] Boehringer Ingelheim Pharma GmbH & Co. KG,undefined
来源：
Pharmaceutical Research | 2020年 / 37卷
关键词：
drug-drug interaction (DDI); furosemide; organic anion transporter (OAT); physiologically based pharmacokinetic modeling (PBPK); probenecid;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Physiologically Based Pharmacokinetic Modeling to Simulate CYP3A4-Mediated Drug-Drug Interactions for Pyrotinib
    Ni, Liang
    Zheng, Liang
    Liu, Yueyue
    Xu, Wenwen
    Zhao, Yingjie
    Wang, Ling
    Zhang, Qian
    Hu, Wei
    Chen, Xijing
    ADVANCES IN THERAPY, 2023, 40 (10) : 4310 - 4320
  • [32] Comment on the Article “Physiologically Based Modeling of Pravastatin Transporter-Mediated Hepatobiliary Disposition and Drug-Drug Interactions”
    Sibylle Neuhoff
    Geoff T. Tucker
    Pharmaceutical Research, 2013, 30 : 1467 - 1468
  • [33] Comment on the Article "Physiologically Based Modeling of Pravastatin Transporter-Mediated Hepatobiliary Disposition and Drug-Drug Interactions"
    Neuhoff, Sibylle
    Tucker, Geoff T.
    PHARMACEUTICAL RESEARCH, 2013, 30 (06) : 1467 - 1468
  • [34] Physiologically based pharmacokinetic modeling to predict OAT3-mediated drug-drug interactions of meropenem in varying stages of chronic kidney disease
    Dong, Jing
    Liu, Jinyao
    Liu, Yanhui
    Yao, Jiachen
    Lu, Yan
    Jiao, Zheng
    Li, Wenyan
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 183
  • [35] APPLICATION OF A PHYSIOLOGICALLY BASED PHARMACOKINETIC (PBPK) MODEL FOR PREDICTION OF THE DRUG-DRUG INTERACTION (DDI) BETWEEN LORAZEPAM AND PROBENECID
    Neuhoff, Sibylle
    Musther, Helen
    Rowland-Yeo, Karen
    DRUG METABOLISM REVIEWS, 2015, 47 : 121 - 121
  • [36] Predictive Performance of Physiologically-Based Pharmacokinetic Models in Predicting Drug-Drug Interactions Involving Enzyme Modulation
    Hsueh, Chia-Hsiang
    Hsu, Vicky
    Pan, Yuzhuo
    Zhao, Ping
    CLINICAL PHARMACOKINETICS, 2018, 57 (10) : 1337 - 1346
  • [37] Evaluation of Drug-Drug Interactions Between Clarithromycin and Direct Oral Anticoagulants Using Physiologically Based Pharmacokinetic Models
    Yang, Zhuan
    Qu, Yuchen
    Sun, Yewen
    Pan, Jie
    Zhou, Tong
    Yu, Yunli
    PHARMACEUTICS, 2024, 16 (11)
  • [38] Physiologically based pharmacokinetic modeling of disposition and drug-drug interactions for valproic acid and divalproex
    Conner, Todd M.
    Nikolian, Vahagn C.
    Georgoff, Patrick E.
    Pai, Manjunath P.
    Alam, Hasan B.
    Sun, Duxin
    Reed, Ronald C.
    Zhang, Tao
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 111 : 465 - 481
  • [39] A Physiologically Based Pharmacokinetic Model for Optimally Profiling Lamotrigine Disposition and Drug-Drug Interactions
    Conner, Todd M.
    Reed, Ronald C.
    Zhang, Tao
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2019, 44 (03) : 389 - 408
  • [40] Physiologically based pharmacokinetic modeling of ponatinib to describe drug-drug interactions in patients with cancer
    Morita, Tomoko O.
    Hanada, Kazuhiko
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2022, 90 (04) : 315 - 323
12345